Modulation of cytochrome C oxidase activity to attenuate brain ischemia/reperfusion injury

huttemann-mitochondria-2018Prof. Maik Hüttemann from the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, USA will give a presentation entitled “Therapeutic application of specific near-infrared light wavelengths that inhibit cytochrome c oxidase results in robust neuroprotection” during the 9th World Congress on Targeting Mitochondria, which will be held at Steigenberger Hotel, Berlin on October 23-25, 2018.

His research focuses cytochrome c oxidase (COX) and the small electron carrier cytochrome c (Cytc), which together catalyze the terminal reaction of the electron transport chain. His group studies basic  processes, such as cell signaling pathways that act on COX and Cytc, which are often dysregulated in human diseases and under cellular stress conditions. His translational interest is geared toward the development of a new and non-invasive technology for the treatment of ischemia-reperfusion injury using infrared light.
 
Prof. Maik Hüttemann was awarded during Targeting Mitochondria 2017 for his short oral presentation on this study. In 2018, he will present an update about the results. For more information about this award, please click here.
 
For more information about Targeting Mitochondria 2018, please visit www.targeting-mitochondria.com

Mitochondria in the Press & Media

  • 1
  • 2
Prev Next

 

News archive